PANS' Lisa Woodill speaks with Stacey Smith, Community Pharmacist & Certified Diabetes and Bariatric Educator, on the trending topic of Ozempic, how Wevovy is being used to treat obesity and ways pharmacists can support patients with side effects & managing their new life style.

Stacey Smith is a Certified Diabetes Educator (CDE) and a Certified Bariatric Educator (CBE) who has practiced in primary care as a consultant pharmacist in the area of diabetes and obesity management for the past 16 years. Stacey’s declarations and conflict(s) of interest include the following: She has received honorariums and payments from Novo Nordisk, Abbott and Dexcom in the past. She has also participated in research/clinical trials sponsored by BD and has been included in Novo Nordisk’s advisory boards. Stacey currently works at a community pha ...